Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlantic Canada’s Value Proposition Re$earch Money Conference November, 2007 Halifax, Nova Scotia Atlantic Canada’s Value Proposition Context to remarks • • • • Understanding BioVectra Inc. and Diagnostic Chemicals Limited Our in-house research capabilities and focus Our collaborations with Atlantic Canada researchers and organizations Our collaborations with Pharmaceutical and Diagnostic companies DCL and BioVectra • Founded in 1970 by Dr. Regis Duffy • Privately held and controlled • DCL employs over 240 people in 3 countries • Four manufacturing facilities plus administration headquarters in Canada; sales and distribution offices in the United States and Mexico • Develops, manufactures and markets products worldwide DCL and BioVectra Prince Edward Island, Canada • Manufacturing / Packaging • Administration • Research and Development • Quality Control • Regulatory Affairs • Technical Services Oxford, Connecticut • Customer Services and Warehousing • Field Sales and Technical Services Mexico City, Mexico • Customer Services and Warehousing • Sales and Field Technical Services Corporate Overview Revenue 2003-2007 40,000 35,000 30,000 25,000 20,000 Revenue 15,000 10,000 5,000 0 2003 2004 2005 2006 2007 DCL and BioVectra Actual and Projected Revenue 60000 50000 40000 30000 Revenue 20000 10000 0 2003 2004 2005 2006 2007 2008 2009 Diagnostics Develops, manufactures and markets worldwide: • Chemistry reagents for human and veterinary diagnostics • Specialty / Niche chemistry reagents for human and veterinary diagnostics • Immunochromatographic point-of-care assays • Laboratory consumable manufacturing on a contract basis Provides services in: • Contract Sales and Distribution • Custom product formulations/manufacturing • Lyophilization, dry and liquid blending • Full kitting including dispensing and labeling • Applications development / FDA filing Diagnostics Strategy R & D: External Collaboration • • • Diagnostic companies with problem chemistries Universities with technologies in clinical chemistry Small firms or individuals with unique chemistries Internal Activities • focus on product development Diagnostics – keys to success Focus on Manufacturing Excellence Unique Products Customer Service Human capital A very good fit with Genzyme Corporation • • • • • • BioVectra is a cGMP manufacturer of APIs and advanced intermediates Fermentation Bioextractions and purifications PEG reagents & PEGylation services Specialty biochemicals and enzymes Creating partnerships with others utilizing our applied technologies to improve or enhance new and existing products BioVectra R & D: External collaboration • • • • Pharma and Biotech companies with unique problems Universities NRC-INH Drug discovery companies BioVectra R & D: Internal Activities • • • PEGs ( a product used as part of the drug, to extend stability and improve performance ) Taxanes – to gain an advantage in generic introduction of a semi-synthetic version of a major oncology drug New Drug Development program – a structure to invest in development of selected candidates BioVectra Keys to Success: • • • • Focus on Manufacturing Excellence Unique Products Customer Service Human Capital Atlantic Canada’s Value Proposition North American strategic location Good cost base for technical activities and manufacturing Quality of life for employees is appreciated and creates loyalty Low bureaucracy, ‘can-do’ attitude Excellent public support climate Institutional support - NRC, AVC, Universities Atlantic Canada Value Proposition Strong support and collaborative system in place; example - PEI BioAlliance Canadian Business 2007 ranked Charlottetown as the 2nd best place to do business in Canada Provincial Tax Incentives – Corporate tax, HR Recruitment support ACOA Atlantic Innovation Fund (AIF) reduces product development risks Some challenges Experience base is limited among available labor Challenging to retain young mobile talent Must overcome perceptions of remote location – access is an issue Removed from financial sources typically used by competition Atlantic Canada’s Value Proposition Atlantic Canada can contribute to the national science and business goals Think about it; • Strong university environment • Well educated work force • Strong work ethic • Entrepreneurial spirit • Local government willing to support economic innovation Atlantic Canada’s Value Proposition Some comments: Message to Governments – “Atlantic Canada is stepping up” as a serious business contender in the science area ACOA- AIF is an important tool for technology transfer and commercialization Maintain and improve competitive tax incentives for science based businesses Develop policies and incentives to attract world-class researchers and highly qualified personnel Invest more in infrastructure and less on strategic forms Atlantic Canada’s Value Proposition This sector is an opportunity for Atlantic Canada to shine – We are committed to making this happen